Tecsys Inc. · TSX:TCS

Tecsys — Q1 2027 Earnings Presentation

22 slides from Tecsys's earnings presentation, Sep 11, 2026

  1. Slide 1: Investor Presentation Q1 FY2027

    The heartbeat of modern supply chains. VISIBILITY. AGILITY. CONFIDENCE IN EVERY OUTCOME. Investor Presentation Q1 FY2027 TRUSTED TO DELIVER. BUILT FOR GROWTH.

  2. Slide 2: Safe harbour

    Safe harbour The statements in this presentation relating to matters that are not historical fact are forward-looking statements that are based on management's beliefs and assumptions. Such statements are not guarantees of future performance, and are subject to a number of uncertainties, including b

  3. Slide 3: Our story is all about our customers

    To ensure the most complex supply chains run without skipping OUR VISION a beat — with visibility, agility and confidence, even in the most unpredictable environments. TECSYS AT A GLANCE We power supply chains that work in the real world — Our story is OUR MISSION combining flexible solutions with t

  4. Slide 4: Trusted provider of supply chain technology

    40+ years 15 times 40% of Gartner’s Healthcare of complex Tecsys named in Supply Chain Top 25 for supply chain the Gartner Magic 2025 are Tecsys experience Quadrant for WMS customers Trusted provider of supply chain technology for the world’s most complex supply networks 4

  5. Slide 5: Global reach and financial strength

    Global reach and financial strength 1,000+ 23% $197M $94M 689 Customer sites EliteTM SaaS Total revenue* SaaS annual Employees** revenue growth* 75% USA recurring revenue** 16% Canada 9% ROW (primarily Europe) * Last twelve months, July 31, 2026 5 ** On July 31, 2026

  6. Slide 6: Elite

    End-to-end integrated supply chain management solutions. An AI-enabled technology platform for success. POU Point of use CONSUME PLAN BUY STORE SELL FULFILL Demand Procurement, Warehousing E-commerce, order Distribution, COMPLETE forecasting and contracting and and inventory management and pick, pac

  7. Slide 7: Recurring revenue evolution

    Recurring revenue evolution Recurring revenue as a percentage of total revenue 60% 58% 56% 50% SaaS growth driving recurring revenue to 60% of total revenue for the quarter ended July 31, 2026 2024 2025 2026 Q1 2027 7

  8. Slide 8: Customers

    Customers Percentage of SaaS annual recurring revenue 83% 17% Healthcare General distribution Solutions built on experience: Delivering end-to-end solutions with technology and services 8

  9. Slide 9: Healthcare supply chains are stressed

    Healthcare supply chains are stressed ▪ Point of use breakdowns ▪ Fragmented ▪ Drug shortages dominate standardization and data- disruptions sharing across networks ▪ No real-time visibility ▪ Dynamic regulatory across inventory and care requirements settings ▪ Extraordinary pressure on supply chain

  10. Slide 10: Total supply chain software ARR market size

    Total supply chain software ARR market size Target addressable market GENERAL H E A LT H S Y S T E M S DISTRIBUTION AND PROVIDERS $9.8B $2.8B U.S./CAN: $6.1B Total market U.S./CAN W. EU: $3.7B ARR $12.6B Western European market estimated at 60% of U.S./Canada market All amounts are presented in Cana

  11. Slide 11: Our focus on end-to-end healthcare supply chain

    Our focus on end-to-end healthcare supply chain Key segments within total addressable market H E A LT H C A R E H E A LT H S Y S T E M S SUPPLIERS AND PROVIDERS Focus areas Focus areas Life sciences and biomedical Medical and pharmaceutical distribution ARR Large IDNs Multisite health systems Health

  12. Slide 12: U.S. health systems and providers market opportunity

    U.S. health systems and providers market opportunity Becoming dominant in U.S. health systems market: The $1.6B ARR* opportunity Health systems Base account market share penetration 409 32% ARR opportunity: ARR opportunity 86% $1.6B 14% with current base: Target health systems $153M 68% Market oppor

  13. Slide 13: Additional ARR from markets where we excel

    Additional ARR from markets where we excel Opportunities within selected non-healthcare market segments in U.S., Canada and Western Europe GENERAL WHOLESALE AND E-COMMERCE $105M GENERAL MARKETS, 3PL PROVIDERS AND Additional H E AV Y M A C H I N E R Y ARR INDUSTRIAL AND $72M E L E C T R I C A L S U P

  14. Slide 14: Partner ecosystem - Accelerate growth

    Delivering exceptional innovation and service together Partner ecosystem - Accelerate growth TECHNOLOGY PARTNERS ADVISORY AND SERVICE PARTNERS AWS, Workday, Oracle, Locus Robotics, Deloitte, KPMG, Avalon CSC, RiseNow Zebra Technologies, TraceLink and Consulting, Sequoia Group and Berkeley Autostore

  15. Slide 15: SaaS annual recurring revenue (ARR) growth

    SaaS annual recurring revenue (ARR)1 growth in $CAD millions 93.7 24% 86.8 83.3 81.1 79.3 Q1 FY27 EliteTM SaaS ARR2 growth YoY (22% on a constant currency basis) 18% Q1 FY27 SaaS ARR1 growth YoY (17% on a constant currency basis) Q1 FY26 Q2 FY26 Q3 FY26 Q4 FY26 Q1 FY27 1 Refer to July 31, 2026, Mana

  16. Slide 16: Elite SaaS ARR net retention rate

    Elite SaaS1 ARR net retention rate 115% 113% 111% 110% 106% 106% 105% 102% 111% LTM Q1 2027 100% EliteTM SaaS1 ARR net retention rate 95% Net Retention = (Existing customer expansion less 90% churn) divided by Beginning period EliteTM SaaS1 ARR 85% 80% 2023 2024 2025 2026 LTM Q1 2027 16 1 Refer to J

  17. Slide 17: SaaS remaining performance obligation (RPO)

    SaaS remaining performance obligation (RPO)1 in $CAD millions 259 243 217 197 14% Q1 2027 SaaS RPO1 YoY Growth (13% on 138 a constant currency basis) 2023 2024 2025 2026 Q1 2027 17 1 Refer to July 31, 2026, Management Discussion and Analysis “Key Performance Indicators”

  18. Slide 18: Projected SaaS margin expansion

    Projected* SaaS margin expansion ▪ Previously sub-scale SaaS business at an inflection point. ▪ Current EliteTM product margins on latest infrastructure are running at over 75%. ▪ AEBITDA FY27P represents guidance mid-point. ▪ AEBITDA FY28P is a directional target. * Refer to July 31, 2026, Manageme

  19. Slide 19: Financial highlights

    Financial highlights in $CAD thousands except EPS Q1 2027 Q1 2026 Δ YoY Q1 2027 TTM Q1 2026 TTM Δ YoY $ % $ % $ % $ % $ % $ % SaaS Revenue 22,652 45% 19,139 42% 3,513 18% 83,925 43% 70,896 39% 13,029 18% Maintenance and Support Revenue 7,386 15% 7,857 17% (471) -6% 30,223 15% 31,612 18% (1,389) -4%

  20. Slide 20: Corporate overview

    Corporate overview $482M 36¢ 16% Market cap** Symbol TCS Dividend per year* Insider ownership** 14.4M S/O ▪ ATB Cormark Capital Markets ▪ Canaccord Genuity Corp Brokerage ▪ National Bank Financial Raymond James coverage ▪ ▪ Stifel ▪ TD Cowen * Last twelve months, July 31, 2026 20 ** On July 31, 2026

  21. Slide 21: Reasons to invest

    Well positioned to dominate global $3B ARR TAM across $3B ARR TAM health systems and targeted distribution markets Reasons 23% LTM ELITETM SAAS REVENUE GROWTH EliteTM SaaS revenue is the primary contributor to total SaaS revenue and growing at 23% LTM. to invest 2.2X NTM Trading at 2.2x NTM EV/sales

  22. Slide 22: Thank you.

    Thank you. The heartbeat of modern supply chains. VISIBILITY. AGILITY. CONFIDENCE IN EVERY OUTCOME.

TECSYS — Q1 2027 Earnings Presentation on 6ix